The nucleic acid amplification testing global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Nucleic Acid Amplification Testing Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The nucleic acid amplification testing market size has grown rapidly in recent years. It will grow from $8.33 billion in 2023 to $9.56 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to rising awareness of infectious disease diagnosis, the emergence of new pathogens, the shift towards personalized medicine, demand for point-of-care testing, regulatory approvals, and guidelines.
The nucleic acid amplification testing market size is expected to see rapid growth in the next few years. It will grow to $16.77 billion in 2028 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to the increasing incidence of infectious diseases, the need for large-scale testing capabilities, increasing investments from private companies, increasing demand for rapid and accurate testing methods, and increasing demand for advanced diagnostic measures. Major trends in the forecast period include integration with artificial intelligence (AI), advancement in wearable and implantable devices, growing adoption in point-of-care testing, expansion in personalized medicine, and integration with digital health technologies.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/nucleic-acid-amplification-testing-global-market-report
Scope Of Nucleic Acid Amplification Testing Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Nucleic Acid Amplification Testing Market Overview
Market Drivers –
The increasing incidence of infectious diseases is expected to propel the growth of the nucleic acid amplification testing market going forward. Infectious diseases are conditions caused by organisms that can spread directly or indirectly from one person to another via various means, such as physical contact, airborne transmission, contaminated food or water, or vector-borne spread via insects. The increase in infectious diseases is due to antibiotic resistance, climate change, changes in human behavior, and agricultural practices. Nucleic acid amplification testing (NAAT) rapidly and accurately identifies infectious pathogens, facilitating timely diagnosis and treatment, thereby helping to control the spread of diseases. For instance, in October 2023, according to the Public Health Agency of Canada, a Canada-based government agency, in the 2022–2023 season, participating provinces and territories reported 4,216 hospitalizations related to influenza. Therefore, the increasing incidence of infectious diseases drives the growth of the nucleic acid amplification testing market.
Market Trends –
Major companies operating in the nucleic acid amplification testing market are focusing on developing innovative solutions, such as in vitro diagnostics (IVD) assays, to screen donated blood for CMV by nucleic acid amplification technology (NAT) under the IVDR. An IVD (in vitro diagnostic) assay is a test performed on biological samples to detect diseases, conditions, or infections outside the body in a laboratory setting. For instance, in June 2024, GFE, a Germany-based company, launched the PoET CMV. PoET CMV, an IVD assay, is designed for the rapid and precise detection of cytomegalovirus (CMV) infections. Its unique features include high sensitivity and specificity, allowing for early diagnosis and effective monitoring of CMV in transplant patients and immunocompromised individuals. The assay utilizes advanced molecular techniques to deliver reliable results quickly, supporting timely clinical decision-making.
The nucleic acid amplification testing market covered in this report is segmented –
1) By Type: Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
2) By Product Type: Consumables, Instruments Or Systems
3) By Technology: Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
4) By Application: Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
5) By End-Use: Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users
Get an inside scoop of the nucleic acid amplification testing market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19619&type=smp
Regional Insights –
North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation< /b>
Table of Contents
1. Executive Summary
2. Nucleic Acid Amplification Testing Market Report Structure
3. Nucleic Acid Amplification Testing Market Trends And Strategies
4. Nucleic Acid Amplification Testing Market – Macro Economic Scenario
5. Nucleic Acid Amplification Testing Market Size And Growth
…..
27. Nucleic Acid Amplification Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore Our Related Reports
https://topprnews.com/global-high-temperature-grease-and-lubricants-market-driver/
https://topprnews.com/global-indoor-farming-market-growth/
https://topprnews.com/global-islamic-finance-market-growth/
https://goodprnews.com/global-high-temperature-grease-and-lubricants-market-analysis/
https://goodprnews.com/global-indoor-farming-market-report/
https://goodprnews.com/global-islamic-finance-market-size/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
